home / lobbying / lobbying_filings_raw

lobbying_filings_raw: 21117108-91c7-4cdc-9dc9-5cf7d887abc4

Raw lobbying disclosure filings from the Senate Office of Public Records (SOPR). Each row is a single filing — registrations, quarterly reports, amendments, and terminations. Includes registrant and client names, reported income/expenses, filing period, and the full raw JSON from the API. Sortable columns (indexed): filing_type, client_name, filing_year, client_state, registrant_state, registrant_house_id, registrant_id. Sorting on any other column returns HTTP 400 (2026-09-04, #697) — use ?sql= with your own ORDER BY if you need it.

This data as json

filing_uuid filing_type registrant_id registrant_name client_id client_name filing_year filing_period received_date is_amendment is_no_activity is_termination raw_json registrant_state registrant_country registrant_house_id client_state client_ppb_state client_country client_ppb_country client_general_description client_government_entity affiliated_org_count client_entity_id client_government_unit_id client_match_method client_match_confidence income_amount expense_amount
21117108-91c7-4cdc-9dc9-5cf7d887abc4 4T 401103474 AVANIR PHARMACEUTICALS 198934 AVANIR PHARMACEUTICALS 2022 fourth_quarter 2022-11-22T09:03:47-05:00 0 0 1 {"url": "https://lda.senate.gov/api/v1/filings/21117108-91c7-4cdc-9dc9-5cf7d887abc4/", "filing_uuid": "21117108-91c7-4cdc-9dc9-5cf7d887abc4", "filing_type": "4T", "filing_type_display": "4th Quarter - Termination", "filing_year": 2022, "filing_period": "fourth_quarter", "filing_period_display": "4th Quarter (Oct 1 - Dec 31)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/21117108-91c7-4cdc-9dc9-5cf7d887abc4/print/", "filing_document_content_type": "text/html", "income": null, "expenses": "40000.00", "expenses_method": "A", "expenses_method_display": "A", "posted_by_name": "Krista Clark", "dt_posted": "2022-11-22T09:03:47-05:00", "termination_date": "2022-11-15", "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "30 Enterprise", "registrant_address_2": "Suite 400", "registrant_different_address": false, "registrant_city": "Aliso Viejo", "registrant_state": "CA", "registrant_zip": "92656", "registrant": {"id": 401103474, "url": "https://lda.senate.gov/api/v1/registrants/401103474/", "house_registrant_id": null, "name": "AVANIR PHARMACEUTICALS", "description": "â\u20ac\u2039Central Nervous System Pharmaceutical Research and Development/Pharmaceutical Sales", "address_1": "30 Enterprise", "address_2": "Suite 400", "address_3": null, "address_4": null, "city": "Aliso Viejo", "state": "CA", "state_display": "California", "zip": "92656", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "KRISTA CLARK", "contact_telephone": "+1 949-389-6768", "dt_updated": "2023-06-06T16:25:15.024382-04:00"}, "client": {"id": 198934, "url": "https://lda.senate.gov/api/v1/clients/198934/", "client_id": 12, "name": "AVANIR PHARMACEUTICALS", "general_description": null, "client_government_entity": false, "client_self_select": true, "state": "CA", "state_display": "California", "country": "US", "country_display": "United States of America", "ppb_state": "CA", "ppb_state_display": "California", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2021-08-18"}, "lobbying_activities": [{"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. H.R. 19, S. 2164, Lower Costs, More Cures Act of 2021. H.R. 5376, Build Back Better Act, specifically issues dealing with Medicare.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 121752, "prefix": null, "prefix_display": null, "first_name": "CATHERINE", "nickname": null, "middle_name": "DRATZ", "last_name": "FERGUSON", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "H.R.7667 - Food and Drug Amendments of 2022, specifically provisions regarding the Prescription Drug User Fee Act (PDUFA). H.R.5376 - Inflation Reduction Act of 2022, specifically provisions relating to prescription drug pricing. Issues related to mental health.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 121752, "prefix": null, "prefix_display": null, "first_name": "CATHERINE", "nickname": null, "middle_name": "DRATZ", "last_name": "FERGUSON", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} CA US   CA CA US US   0 0           40000.0

Links from other tables

  • 2 rows from filing_uuid in lobbying_activities
  • 1 row from filing_uuid in lobbying_lobbyists
  • 0 rows from filing_uuid in lobbying_affiliated_orgs
Powered by Datasette · Queries took 0.473ms · Privacy